Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.

Journal Information

Full Title: Respir Med

Abbreviation: Respir Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest Stina Selberg declarations of interest: none. Johanna Karlsson Sundbaum declarations of interest: none. Jon R. Konradsen declarations of interest: none. Helena Backman has received personal fees for scientific presentations from AstraZeneca, Boehringer Ingelheim, and Glaxo Smith Kline, outside the submitted work. Linnea Hedman declarations of interest: none. Anne Lindberg reports personal fees from Boehringer Ingelheim, GlaxoKlineSmith, AztraZeneca and Novartis outside the submitted work. Caroline Stridsman has served in an advisory board and/or participated in education arranged by AstraZeneca, Boehringer Ingelheim, and Novartis."

Evidence found in paper:

"Funding This work was supported by the 10.13039/501100003793Swedish Heart-Lung Foundation under Grant 20200308, the 10.13039/501100010234Asthma and Allergy Association, Region Norrbotten and the Swedish Respiratory Society."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025